Drugs / ATI-7505
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01094821 | Jan → Dec 2005 | — | Mayo Clinic | Completed | Mixed |
| Phase 22 trials | ||||||
| Phase 2 | NCT00630370 | Feb → Jul 2008 | — | Procter and Gamble | Terminated | No outcome recorded |
| Phase 2 | NCT00501241 | Jul 2007 → Jul 2008 | constipation disorder | Procter and Gamble | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATI 7505 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00630370 ↗ |
| Action | Activate | “ATI-7505, an investigational 5-HT(4) receptor agonist” PMID 17187586 ↗ Jan 2007 |
| Route | Oral | “1 ATI 20mg and 1 placebo tablet, TID, orally, 58 days” NCT00630370 ↗ |